Ear Wax Relief (Similasan Corporation)


Welcome to the PulseAid listing for the Ear Wax Relief drug offered from Similasan Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Similasan Corporation
NON-PROPRIETARY NAME: causticum, graphite, lachesis muta venom and lycopodium clavatum spore
SUBSTANCE NAME: CAUSTICUM; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: AURICULAR (OTIC)
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2003-06-01
END MARKETING DATE: 0000-00-00


Ear Wax Relief HUMAN OTC DRUG Details:

Item DescriptionEar Wax Relief from Similasan Corporation
LABELER NAME: Similasan Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 15; 12; 12([hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL; [hp_X]/10mL)
START MARKETING DATE: 2003-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59262-272_695616d1-adfe-407e-9e36-713040ce0928
PRODUCT NDC: 59262-272
APPLICATION NUMBER:

Other CAUSTICUM; GRAPHITE; LACHESIS MUTA VENOM; LYCOPODIUM CLAVATUM SPORE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Similasan CorporationEar Wax Relief